11. Prior Treatment: Previously untreated or has received a maximum of one cycle of any combination chemotherapy (e.g. CHOP, CHOEP, DA-EPOCH, CODOX-M/IVAC, HyperCVAD) within 4 weeks of study entry. Additionally, a patient may have taken antiretroviral therapy (e.g. AZT and/or IFN) at any time prior to study enrollment